Contract manufacturing organisation 08/01/2021 Creating a Next Generation CDMO An interview with Jerrod Denham, VP of Manufacturing at Ology Bioservices
Gene therapy 24/11/2020 AAV vector manufacturing: Transfection matters Optimising the transfection process and its efficiency is paramount to boosting vector titres during scale-up and manufacturing of AAV vectors with new generation transfection reagents
GMP manufacturing 02/11/2020 Advanced Therapies Manufacturing Capacity in North America A comprehensive guide showcasing the growing cell and gene therapy and viral vector manufacturing landscape in North America
Raw materials 13/10/2020 Exploring Dedicated Donor Paradigms as a Solution to Advanced... By Dominic Clarke, Global Head of Cell Therapy at HemaCare
CAR-T 30/09/2020 The Evolving Process of Clinical CAR-T Manufacturing in an Academic... A presentation with Isabelle Riviere, Director, Michael G. Harris Cell Therapy and Cell Engineering Laboratory...
Bioprocessing 28/09/2020 Technology Review: In-process Analytics for Advanced Therapies Edition Three of Phacilitate’s technology review series examines in-process analytics tools that will innovate and improve...
Commercialisation 18/09/2020 Episode 6 David Smith, Akron Biotech and Oliver Ball, Stemmatters Dave and Oli share their views on what's slowing down cell therapy approval rates
Bioprocessing 15/09/2020 [WEBINAR] Point of Care Manufacturing for Next-Generation Advanced... On-demand access to a live webinar from 22nd October 2020
patient access 02/09/2020 Enabling Patient Access to Personalised Cell Therapies Through... Dr Ohad Karnieli talks to us about point-of-care manufacturing challenges, solid tumour treatments and taking inspiration from....
Raw materials 01/09/2020 Survey: Automating Raw Materials Processes in Cell and Gene Therapy... How are you approaching automation of raw materials processes?
Automation 27/08/2020 Embedding Flexibility into Automated Bioprocessing An interview with Sean Werner, President, Sexton Biotechnologies
Contract manufacturing organisation 08/07/2020 Advanced Therapies Manufacturing Capacity in Europe 2020 A comprehensive guide showcasing Europe's cell and gene therapies and viral vector manufacturing landscape
Raw materials 21/05/2020 Overcoming Raw Material Challenges in Cell and Gene Therapy... A briefing with CellGenix and friends
viral vectors 06/05/2020 [WEBINAR] Case Study: Process Development and Large-scale GMP... How efficient are your lentiviral vector large-scale production and purification processes?
Bioprocessing 29/04/2020 [WEBINAR] Reproducibility, Reliability, Robustness: Establishing... Which manufacturing parameters have significant effects on product performance?
